HPV Vaccine Refusal Explored Among Cancer Survivors
MONDAY, Dec. 19, 2022 -- Cancer survivors refusing participation in a trial assessing the safety and immunogenicity of the human papillomavirus (HPV) vaccine do so mainly due to vaccine-related concerns, according to a study published online Dec. 19...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer Vaccine | Genital Warts | Human Papillomavirus (HPV) | Pharmaceuticals | Study | Vaccines